Literature DB >> 21099102

Can TNF-α boost regulatory T cells?

Angelina M Bilate1, Juan J Lafaille.   

Abstract

Deleterious immune responses that cause autoimmune diseases such as type 1 diabetes are normally kept in check by a myriad of mechanisms. Among these, protection mediated by CD4+Foxp3+ Tregs constitutes an essential pathway. Much work over the past decade aimed to understand how Tregs affect immune responses triggered by effector T cells (Teffs), but less is known about how Teffs affect Tregs. In this issue of the JCI, Grinberg-Bleyer et al. report the clearest example thus far regarding this important aspect of Treg biology. They find that in mice, sustained protection from diabetes by Tregs is dependent on Teffs and partially dependent on TNF-α, a cytokine traditionally considered proinflammatory.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099102      PMCID: PMC2993605          DOI: 10.1172/JCI45262

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.

Authors:  Maria A Curotto de Lafaille; Andreia C Lino; Nino Kutchukhidze; Juan J Lafaille
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

3.  Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells.

Authors:  Afonso R M Almeida; Bruno Zaragoza; Antonio A Freitas
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

Authors:  Yenkel Grinberg-Bleyer; David Saadoun; Audrey Baeyens; Fabienne Billiard; Jérémie D Goldstein; Sylvie Grégoire; Gaëlle H Martin; Rima Elhage; Nicolas Derian; Wassila Carpentier; Gilles Marodon; David Klatzmann; Eliane Piaggio; Benoît L Salomon
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

5.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

6.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.

Authors:  Xavier Valencia; Geoffrey Stephens; Raphaela Goldbach-Mansky; Mildred Wilson; Ethan M Shevach; Peter E Lipsky
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

9.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

10.  Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Authors:  Gláucia C Furtado; Maria A Curotto de Lafaille; Nino Kutchukhidze; Juan J Lafaille
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  8 in total

Review 1.  The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 2.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

3.  BST2/Tetherin is constitutively expressed on human thymocytes with the phenotype and function of Treg cells.

Authors:  Marta Epeldegui; Bianca Blom; Christel H Uittenbogaart
Journal:  Eur J Immunol       Date:  2014-12-16       Impact factor: 5.532

4.  Differential control of Helios(+/-) Treg development by monocyte subsets through disparate inflammatory cytokines.

Authors:  Hui Zhong; Karina Yazdanbakhsh
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

5.  An in silico modeling approach to understanding the dynamics of sarcoidosis.

Authors:  Baltazar D Aguda; Clay B Marsh; Michael Thacker; Elliott D Crouser
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

6.  Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39+/CD73+ Murine Monocytes Modulate Intestinal Inflammation via Induction of Regulatory T Cells.

Authors:  Toni Weinhage; Jan Däbritz; Anne Brockhausen; Timo Wirth; Markus Brückner; Michael Belz; Dirk Foell; Georg Varga
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-05-06

7.  TNFα-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression.

Authors:  Paulo C M Urbano; Xuehui He; Bennie van Heeswijk; Omar P S Filho; Henk Tijssen; Ruben L Smeets; Irma Joosten; Hans J P M Koenen
Journal:  Front Immunol       Date:  2020-01-21       Impact factor: 7.561

8.  TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.

Authors:  Anais Debesset; Caroline Pilon; Audrey Moatti; Asma Beldi-Ferchiou; Mathieu Leclerc; Rabah Redjoul; Frederic Charlotte; Nhu Hanh To; Adeline Bak; Yazid Belkacemi; Benoît Laurent Salomon; Fadi Issa; David Michonneau; Sebastien Maury; José Laurent Cohen; Allan Thiolat
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.